CDMO250117C20000
- 0.00
- 0.000.00%
Avid Bioservices Newsroom
Avid Bioservices (CDMO) Started a Sale Process
Press Release: Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and Vote FOR the Transaction With GHO and Ampersand
Proxy Adviser ISS Said to Recommend Avid Bioservices Holders Vote for Takeover
Vetter Introduces the Next Evolution of the V-OVS Syringe Closure System
RBC Capital Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
RBC Capital Sticks to Its Hold Rating for Avid Bioservices (CDMO)
Havencrest Homecare Platform, Avid Health at Home, Announces Additional Acquisition in North Carolina
Press Release: Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
Express News | Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Gho and Ampersand
Avid Bioservices Insider Sold Shares Worth $1,783,032, According to a Recent SEC Filing
Avid Bioservices Insider Sold Shares Worth $278,775, According to a Recent SEC Filing
Insider Sale: Chief Operations Officer of $CDMO (CDMO) Sells 3,843 Shares
Avid Bioservices, Inc. Proposes Transaction With GHO Capital Partners and Ampersand Capital, Encouraging Stockholder Support
Express News | Avid Bioservices Inc: Special Meeting to Vote on Transaction Scheduled for Jan 30, 2025
Express News | Avid Bioservices Recommends Stockholders Vote for Value Maximizing Transaction
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
Stephens Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Hold Rating
Craig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)
Avid Bioservices Reports 32% Revenue Growth Ahead Of Acquisition